GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

VIVS · Mar 31, 2024

VivoSim Labs, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0000950170-24-067301General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

38.53% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-13443.12% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

-70.54% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

272.48% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-13840.37% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

5044.04% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1383.49% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building

Mar 31, 20230/6 normalizedLevel 3 Dec 31, 20230/6 normalizedLevel 3 Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/8 normalizedLevel 3 Sep 30, 20245/7 normalizedLevel 3 Dec 31, 20245/8 normalizedLevel 3 Mar 31, 20255/8 normalizedLevel 3 Jun 30, 20254/6 normalizedLevel 3 Sep 30, 20255/6 normalizedLevel 3 Dec 31, 20256/7 normalizedLevel 3 Mar 31, 20266/7 normalizedLevel 3 Jun 30, 20266/6 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Increased

Previous: 0.00%
Current: 38.53%
Delta: 38.53%

Cash Generation Increased

Previous: -70440.00%
Current: -13443.12%
Delta: 56996.88%

Growth Increased

Previous: -96.18%
Current: -70.54%
Delta: 25.64%

Profitability Increased

Previous: -73600.00%
Current: -13840.37%
Delta: 59759.63%

R And D Intensity Decreased

Previous: 28680.00%
Current: 5044.04%
Delta: -23635.96%

Sbc Intensity Decreased

Previous: 3140.00%
Current: 1383.49%
Delta: -1756.51%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · VIVS Fundamental State →Has State · VivoSim Labs, INC. →Transitioned To · VIVS Fundamental State →Transitioned To · VIVS CAPEX_INTENSITY_INCREASED →Transitioned To · VIVS CASH_GENERATION_INCREASED →Transitioned To · VIVS GROWTH_INCREASED →Transitioned To · VIVS PROFITABILITY_INCREASED →Transitioned To · VIVS R_AND_D_INTENSITY_DECREASED →Transitioned To · VIVS SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.